Ares Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Ares Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,938	Closed	-$377K	–	17
2015 Q1	$377K	Hold	3,938	–	–	0.04%	7
2014 Q4	$221K	Hold	3,938	–	–	0.02%	7
2014 Q3	$285K	Buy	+3,938	New	+$431K	0.03%	9

Other funds holding GNCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ares Management's GNCA Position: Q2 2015 in Review

Ares Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2015, closing a stake of 3,938 shares — an estimated $377K sold.

Ares Management first reported a position in GNCA in Q3 2014 and held it in 3 quarters. The position peaked at $377K in Q1 2015. 60 funds tracked by Wall St. Rank hold GNCA as of Q2 2015.

Ares Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2015 after selling out during the quarter.
Ares Management sold 3,938 Genocea Biosciences, Inc. shares in Q2 2015, an estimated $377K.
Ares Management first reported a position in Genocea Biosciences, Inc. in Q3 2014 and held it in 3 quarters.
Ares Management's Genocea Biosciences, Inc. position peaked at $377K in Q1 2015.
60 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2015.

Based on Ares Management's 13F filing for Q2 2015, filed 14 Aug 2015.